Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:monoclonal_antibody
|
| gptkbp:alternativeName |
gptkb:acoramidis
|
| gptkbp:clinicalTrialPhase |
Phase 3
|
| gptkbp:developedBy |
gptkb:Eidos_Therapeutics
treatment of transthyretin amyloidosis |
| https://www.w3.org/2000/01/rdf-schema#label |
AG-10
|
| gptkbp:indication |
transthyretin amyloid cardiomyopathy
|
| gptkbp:mechanismOfAction |
stabilizes transthyretin protein
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational drug
|
| gptkbp:target |
gptkb:transthyretin
|
| gptkbp:bfsParent |
gptkb:Barbuda
|
| gptkbp:bfsLayer |
5
|